Parents' intention to get vaccinated and to have their child vaccinated against COVID-19: cross-sectional analyses using data from the KUNO-Kids health study.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 27 11 2020
accepted: 29 04 2021
revised: 01 04 2021
pubmed: 18 5 2021
medline: 13 10 2021
entrez: 17 5 2021
Statut: ppublish

Résumé

A COVID-19 vaccine can be an important key for mitigating the spread of the pandemic, provided that it is accepted by a sufficient proportion of the population. This study investigated parents' intention to get vaccinated and to have one's child vaccinated against COVID-19. In May 2020, 612 parents participating with their child in the KUNO-Kids health study completed an online survey. Multivariable logistic regression models were calculated to analyze predictors of intention to vaccinate. Fifty-eight percent of parents intended to get vaccinated against COVID-19, and 51% intended to have their child vaccinated. Significant predictors for the intention to get vaccinated and for having the child vaccinated included stronger parental confidence in one's knowledge about prevention measures and lower beliefs that policy measures were exaggerated.Conclusion: COVID-19 vaccination hesitancy was considerable in our sample of parents in Germany. However, our study revealed some potentially modifiable factors which should be addressed by a comprehensive and tailored communication and education strategy. What is Known? • A COVID-19 vaccine can mitigate the spread of the pandemic. • Many parents are skeptical about vaccinations in general. What is New? • COVID-19 vaccination hesitancy was considerable in our sample of parents from Germany, not only for getting vaccinated but also for having the child vaccinated. • Negative parental attitudes regarding policy measures to contain the pandemic were associated with a lower intention to vaccinate.

Identifiants

pubmed: 33999257
doi: 10.1007/s00431-021-04094-z
pii: 10.1007/s00431-021-04094-z
pmc: PMC8127511
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3405-3410

Subventions

Organisme : EU
ID : HEALS: 603946
Organisme : German Federal Ministry for Education and Research
ID : 01ZX1306E

Investigateurs

Andreas Ambrosch (A)
Petra Arndt (P)
Andrea Baessler (A)
Mark Berneburg (M)
Stephan Böse-O'Reilly (S)
Romuald Brunner (R)
Wolfgang Buchalla (W)
Sara Fill Malfertheiner (SF)
André Franke (A)
Sebastian Häusler (S)
Iris Heid (I)
Caroline Herr (C)
Wolfgang Högler (W)
Sebastian Kerzel (S)
Michael Koller (M)
Michael Leitzmann (M)
David Rothfuß (D)
Wolfgang Rösch (W)
Bianca Schaub (B)
Bernhard H F Weber (BHF)
Stephan Weidinger (S)
Sven Wellmann (S)

Informations de copyright

© 2021. The Author(s).

Références

Mol Cell Pediatr. 2019 Jan 9;6(1):1
pubmed: 30627823
Eur J Public Health. 2019 Jun 1;29(3):512-516
pubmed: 30801109
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
Vaccine. 2020 Nov 10;38(48):7668-7673
pubmed: 33071002
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):410-421
pubmed: 30788538
Eur J Epidemiol. 2021 Feb;36(2):197-211
pubmed: 33649879
Vaccine. 2018 Jan 25;36(4):442-452
pubmed: 29287683
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389
Clin Ther. 2020 Nov;42(11):2124-2133
pubmed: 33067013
Eur J Public Health. 2012 Aug;22(4):562-8
pubmed: 21750011

Auteurs

Susanne Brandstetter (S)

University Children's Hospital Regensburg (KUNO), Regensburg, Germany. Susanne.brandstetter@barmherzige-regensburg.de.
Member of the Research and Development Campus Regensburg (WECARE), Hospital St. Hedwig of the Order of St. John, Regensburg, Germany. Susanne.brandstetter@barmherzige-regensburg.de.

Merle M Böhmer (MM)

Bavarian Health and Food Safety Authority, Oberschleissheim, Magdeburg, Germany.
Institute of Social Medicine and Health Systems Research, Otto von Guericke University Magdeburg, Magdeburg, Germany.

Maja Pawellek (M)

University Children's Hospital Regensburg (KUNO), Regensburg, Germany.
Member of the Research and Development Campus Regensburg (WECARE), Hospital St. Hedwig of the Order of St. John, Regensburg, Germany.

Birgit Seelbach-Göbel (B)

University Department of Gynecology and Obstetrics, Hospital St. Hedwig of the Order of St. John, University Medical Center Regensburg, Regensburg, Germany.

Michael Melter (M)

University Children's Hospital Regensburg (KUNO), Regensburg, Germany.
Member of the Research and Development Campus Regensburg (WECARE), Hospital St. Hedwig of the Order of St. John, Regensburg, Germany.

Michael Kabesch (M)

University Children's Hospital Regensburg (KUNO), Regensburg, Germany.
Member of the Research and Development Campus Regensburg (WECARE), Hospital St. Hedwig of the Order of St. John, Regensburg, Germany.

Christian Apfelbacher (C)

Member of the Research and Development Campus Regensburg (WECARE), Hospital St. Hedwig of the Order of St. John, Regensburg, Germany.
Institute of Social Medicine and Health Systems Research, Otto von Guericke University Magdeburg, Magdeburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH